InMed Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $659,848 | $1,125 | $1,120 | $1,777 |
Gross Profit | -134 | 35 | 403 | 785 |
EBITDA | -2,658 | -2,566 | -1,570 | -2,437 |
EBIT | -2,791 | -2,782 | -1,726 | -2,509 |
Net Income | -2,966 | -2,782 | -1,726 | -2,435 |
Net Change In Cash | 659,848 | 1,125 | 1,120 | 1,777 |
Free Cash Flow | -1,758 | -3,226 | -2,242 | -1,778 |
Cash | 5,158 | 9,545 | 13,014 | 15,090 |
Basic Shares | 4,048 | 3 | 3 | 2,002 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $4,942 | $4,597 | $4,135 | $1,089 |
Gross Profit | 1,706 | 1,100 | 1,403 | 543 |
EBITDA | -7,255 | -7,063 | -7,338 | -18,088 |
EBIT | -7,790 | -7,668 | -7,934 | -18,600 |
Net Income | -8,162 | -7,675 | -7,947 | -18,600 |
Net Change In Cash | 4,942 | 4,597 | 4,135 | 1,089 |
Free Cash Flow | -7,766 | -6,995 | -7,445 | -15,622 |
Cash | 15,090 | 8,987 | 11,806 | 7,953 |
Basic Shares | 975 | 381 | 122 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.73 |
2025-12-31 | -$0.51 |
2025-09-30 | -$0.43 |
2025-06-30 | -$1.20 |